Trial Profile
Phase III Clinical Study of Intraveous S-021812 in Patients with Influenza Virus Infection - Assessments in Patients with High-Risk Factors -
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Jul 2022
Price :
$35
*
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors Shionogi
- 25 May 2016 New trial record